JP4183800B2 - Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body - Google Patents

Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body Download PDF

Info

Publication number
JP4183800B2
JP4183800B2 JP19505198A JP19505198A JP4183800B2 JP 4183800 B2 JP4183800 B2 JP 4183800B2 JP 19505198 A JP19505198 A JP 19505198A JP 19505198 A JP19505198 A JP 19505198A JP 4183800 B2 JP4183800 B2 JP 4183800B2
Authority
JP
Japan
Prior art keywords
information
storage medium
magnetic field
magnetic storage
pole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP19505198A
Other languages
Japanese (ja)
Other versions
JP2000005326A (en
Inventor
幸則 高橋
卯典 池本
政人 安久津
武美 市村
Original Assignee
武美 市村
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 武美 市村 filed Critical 武美 市村
Priority to JP19505198A priority Critical patent/JP4183800B2/en
Publication of JP2000005326A publication Critical patent/JP2000005326A/en
Application granted granted Critical
Publication of JP4183800B2 publication Critical patent/JP4183800B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Magnetic Treatment Devices (AREA)

Description

【0001】
【産業上の利用分野】
本発明は磁気を通して得た抗原や抗体からの情報により生体の疾病を治療し、活性を促す生物の疾病予防・治療方法及びこの方法に使用する情報記憶媒体並びに情報記憶済みセラミック体に関する。
【0002】
【従来の技術】
近年、魚介甲殻類の増養殖が発展するに伴って、ウイルス性並びに細菌性疾病が多発し甚大な被害をもたらしている。ウイルス病については、とくにマダイ、イシダイ、カンパチ、ブリなどのイリドウイルス感染症及びエビ類のバキュロウイルス感染症による大きな経済的被害が世界的にみられているが、治療薬は未だに開発されていない。細菌性感染症については、類結節症、ビブリオ感染症、エドワジラ感染症などによる経済的被害が大きい。これらの細菌性疾病の治療薬として、多種の抗生物質及び合成抗菌剤が用いられているが、近年、抗生物質にたいして耐性菌が出現し、充分な治療効果が得られない状態にある。また、使用した薬剤の魚介甲殻類の体内残留による公衆衛生上の問題が生じていることから、化学療法に依存しない防疫対策が強く望まれている。
【0003】
一方、魚介甲殻類の免疫機能を増強させて被害を軽減しようとする技術がすでに知られており、一部実用化している。免疫機能増強剤として、ビフィズス菌由来のペプチドグルカンやキノコ由来のβ−1、3−グルカンなどの多糖類があり、開発が進められている。しかし、これらは薬剤を直接生物に投与するものであるから、その都度薬剤が消費されてしまい、コストが高くつく。また、薬剤の直接投与は充分な予防・治療効果が得られないだけでなく、乱用や誤用による弊害も少なくない。
【0004】
【発明が解決しようとする課題】
前述したように、魚介甲殻類の養殖において多くの疾病が発生し、それによる被害額は我が国だけで250億円にも及んでいる。単に経済的な被害にとどまらず、長年かかって積み上げてきた種苗生産、配合飼料、飼育管理や養殖施設機材などの養殖技術をもとにした健全経営が疾病により根底から大きく揺らぎ、産業の存続すら危ぶまれている昨今である。この背景には、薬剤の乱用誤用による耐性菌の出現、新しいウイルスの多発に追いつけない化学薬剤やワクチンの開発、環境悪化や高密度生産によるストレスの負荷及び免疫機能低下が挙げられる。
【0005】
魚介甲殻類の増殖面においても、枯渇した資源の回復をめざした国策として栽培漁業や海洋牧場の諸事業が推進されている。しかしながら、この事業の根幹をなす人工孵化大量生産種苗、放流用稚仔が放流前にウイルスや細菌に感染するケースがここ数年来多発している。大量放流用稚仔のごく一部であっても感染が認められれば、感染の生体検査と識別が機能的に困難であることからその全体を放流することはできず廃棄処分することになる。事後の管理が可能な養殖と比べ、増殖では管理不能であり、疫病を自然界に放流することは許されないからである。
【0006】
従って、本発明の第1の目的は、薬剤やワクチンの直接投与を一切行わずに、生物の抗原活性を低下させ、免疫機能を増進させることにより、生物、特に、魚介甲殻類を健全且つ安全に飼育する生体の疾病予防・治療方法を提供することにある。
【0007】
本発明の第2の目的は、上記の疾病予防・治療方法に使用する情報記憶用の磁気記憶媒体及び磁化水を提供することにある。
【0008】
本発明の第3の目的は、上記の疾病予防・治療方法に使用する情報記憶済み媒体のセラミックス体を提供することにある。
【0008】
【課題を解決するための手段】
上記第1の目的を達成するために、本発明による第1の疾病予防・治療方法は、物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場のN極寄りに、病原体、生体にとっての異物、抗原等又はこれらの情報を記憶させた磁気記憶媒体を配置するとともに、前記直線磁場の外側に生成される湾曲磁場に磁気記憶媒体を置いた後、前記湾曲磁場の媒体又はこの媒体を含む物質を取出して人以外の生物又は生物の飼育環境下に投与することを特徴とする。
【0009】
本発明による第2の疾病予防・治療方法は、物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場のN極寄りに、活性化された白血球その他の細胞、抗体、生体防御機能増強剤、又はこれらの情報を記憶させた磁気記憶媒体などの物体を置くとともに、これら物体よりもS極寄りの前記直線磁場に磁気記憶媒体を置いた後、前記直線磁場のS極寄りに置いた前記媒体又はこの媒体を含む物質を取出して人以外の生物又は生物の飼育環境下に投与することを特徴とする。
【0010】
本発明による第3の疾病予防・治療方法は、上記二つの方法を併用して行うことを特徴とする。
【0011】
上記疾病予防・治療方法に使用する情報記憶用磁気記憶媒体は、酸化鉄フイルム、又はコバルトを被着した酸化鉄フイルムと;ネオジウム、鉄を主材とする永久磁石を希塩酸で溶解した飽和溶液に対して、ゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を10容量%の比率で混和し、これを120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕し、その粉末の水溶液を浸潤させて乾燥したシートと;を貼りあわせたものが好ましい。
【0012】
また、上記疾病予防・治療方法に使用する情報記憶用磁気記憶媒体は、ネオジウム、鉄、硼酸を主材とする永久磁石を希塩酸で溶解した溶液に、これと等量のゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を混和し、この混合液を120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕した粉末の1%水溶液である情報記憶用磁気記憶媒体水が好ましい。
【0013】
上記情報記憶済みの磁気記憶媒体水等の媒体は、これをそのまま人以外の生物又は生物の環境下に投与して使用してもよいが、水で希釈し、あるいは、陶磁材料に混練し、乾燥・焼成したセラミックス体にして使用してもよい。
【0014】
【発明の実施の形態】
以下、本発明の実施形態を添付図面に基づいて説明する。
元素、化合物、生命体、抗原、抗体などの物質は、それぞれ固有の波長波形を持っている。従って、これらの物質の情報を磁気記憶媒体に記憶(転写)させ、再現することができれば、多様な有益目的に利用できる、という着想の下に種々の実験を重ね本発明をなすに至ったものである。
【0015】
この発明のために、先ず、強力な磁気を用いて、物質の情報を磁気記憶媒体に記憶させるために、図1のような磁気装置を用意した。
この装置は、N極とS極を所定間隔を隔てて対向させた馬蹄形磁石などの永久磁石1を使用するもので、磁石1のN極とS極の対向面間にN極からS極に向けて磁力線がまっすぐに向かう直線磁場2が生成される。
また、前記直線磁場2の外側にはN極からS極に向けて磁力線が湾曲して向かう湾曲磁場3が生成される。
【0016】
上記図1の装置を用いて種々の実験を行った。
先ず、実験1として、ウイルスに感染させたエビなどの水産生物を直線磁場2のN極寄りに置き、S極寄りに磁気記憶媒体としての磁気記憶媒体水を置く。約60秒後にこの磁気記憶媒体水(記憶水)を取り出してウイルス感染エビの飼育水に入れると、通常の飼育水中のウイルス感染エビよりも早期に死滅した。
【0017】
他方、実験2として、生体防御(免疫)増強剤で生体防御機能を増強させたエビの血液から採取した血球を直線磁場2のN極寄りに置くとともに、この直線磁場2のS極寄りに磁気記憶媒体としての磁気記憶媒体水を置き、約60秒後にこの磁気記憶媒体水(記憶水)を取り出してウイルス感染エビの飼育水にいれると、通常の飼育水中の正常エビと同等の生存率を示した。
【0018】
このことは、直線磁場2のN極寄りに抗原や抗体を置き、S極寄りに磁気記憶媒体を置くと、その抗原や抗体が持っている固有の情報が磁気記憶媒体に正転写として記憶され、また記憶媒体に記憶された情報は、飼育槽において再現され、飼育槽内のエビに作用しているものと考えられる。
【0019】
ところが、前記実験1に関連する実験3として、ウイルスに感染させたエビなどの水産生物を直線磁場2のN極寄りに置くとともに、磁石1の前記直線磁場2の外側に生成される湾曲磁場3に、磁気記憶媒体を約60秒間置いた後、この媒体をウイルス感染エビの飼育水に入れると、実験2と同様に、通常の飼育水中の正常エビと同等の生存率を示した。
【0020】
また、直線磁場2のN極寄りに生命体の抗原やこの抗原の情報を記憶した記憶媒体のみを置き、前記と同様に湾曲磁場3に磁気記憶媒体を置き、この記憶媒体をウイルス感染エビの飼育水に入れた場合にも実験2と同様に、正常エビと同等の生存率を示した。
【0021】
このことは、直線磁場2のN極寄りに生命体の抗原又は抗原の情報を記憶させた磁気記憶媒体を置き、前記直線磁場2の外側の湾曲磁場3に磁気記憶媒体を置くと、湾曲磁場3に置いた磁気記憶媒体水などの媒体に、前記抗原に対抗する情報(以下、逆情報と云う)が逆転写として記憶され、すなわち、抗ウイルス機能を持った情報として記憶され、エビの飼育環境下に再現されたものと考えられる。
【0022】
次に、本発明の実施形態を例示する。
第1の実施形態は、図2のように、直線磁場2のN極寄りにウイルスなどの病原体、病原体を持つ生命体、又はこれらの情報を記憶させた磁気記憶媒体(以下、抗原4という)を置くとともに、前記湾曲磁場3に磁気記憶媒体5を約60秒間置く。こうすることにより、湾曲磁場3の媒体5に抗原4の情報が逆転写され、媒体5は抗原4に対して対抗力のある情報を持った物質になる。
かくして、この物質を生物の飼料等に混ぜて投与し、あるいは、セラミックスに含有させて飼育水槽に投入し、あるいは、飼育水槽の飼育水として利用することにより、生物の前記病原体による疾病が予防され、治癒される。
【0023】
上記の実施形態において、直線磁場2のN極寄りに置く抗原は、抗原そのものを使用するよりも、その抗原の情報を記憶させた磁気記憶媒体を使用するのがより好ましい。その理由は,抗原は一般に有害物であり、直接扱わずに記憶媒体の形で使用するのが安全だからである。
このような情報を記憶させた磁気記憶媒体は、図3に示すように直線磁場2のN極寄りにウイルスや病原体などのなまの抗原4aを置き、そのS極側に磁気記憶媒体4bを置くことによって生成することができる。すなわち、直線磁場2においてなまの抗原4aの情報が磁気記憶媒体4bに正転写され、なまの抗原4aの情報を記憶させた磁気記憶媒体4bが得られる。
【0024】
本発明の第2の実施形態は、図4に示すように、磁石1の前記直線磁場2のN極寄りに、生体防御機能増強剤又は生体防御機能を増強させた生体組織、もしくはこれらの物質の情報を記憶させた磁気記憶媒体などの物体(以下、抗体6という)を置くとともに、これら抗体6よりもS極寄りの前記直線磁場2に置いた磁気記憶媒体5を約10〜60秒間置いておく。しかるのち、この媒体5を前記と同様の方法で人以外の生物又は生物の飼育環境下に投与するものである。
すなわち、この実施形態は、生体防御機能増強の情報を直線磁場2において磁気記憶媒体に正転写するものである。
【0025】
この場合も、直線磁場2のN極寄りに生体防御機能増強剤又は生体防御機能を増強させた生体組織などの抗体6自体を直接置いてもよいが、好ましくは、抗体6の情報を正転写で記憶させた磁気記憶媒体を置いてもよい。この磁気記憶媒体図3と同じ要領で、磁気装置の前記直線磁場2のN極寄りに抗体6を置き、S極寄りに磁気記憶媒体を置くことによって得られ、約60秒間で磁気記憶媒体は抗体6の情報を記憶した磁気記憶媒体になる。
【0026】
図1乃至図4の磁石装置は本発明の方法に使用される好ましい一例を示すもので、これに限定されるものではない。例えば、図5のように、左右一対の磁石1a、1bを、相互のN極とS極が所定間隔を離して対向するように配置し、相対するN極とS極の対向面間に直線磁場2が生成され、この直線磁場2の外側にこの直線磁場2に沿った湾曲磁場3が生成されるようにした磁石装置を使用することもできる。
【0027】
図5の磁石装置は、さらに、各々の磁石1a、1bのN極からS極に向かう曲線磁場7が生成されるとともに、磁石1aのN極から磁石1bのS極に向かう曲線磁場3が生成されるが、前記逆転写のための媒体5を置く領域は磁石1aのN極から磁石1bのS極に向かう湾曲磁場3である。
なお、図5の装置は上記の直線磁場2、湾曲磁場3、外側曲線磁場8を枠9で区画してある。
【0028】
図5の装置を使用する場合は、直線磁場2の記憶済みの媒体を取り出すときは、外側曲線磁場8の影響をうけないように磁石1a、1bを取り外す必要がある。また、同様の理由で、抗原4の情報を逆転写させた湾曲磁場3の媒体を取り出すには、磁石1a、1b、を取り外すか、湾曲磁場3の磁力線方向の逆方向から取り出す必要がある。
【0029】
本発明の方法に使用する前記情報記憶用磁気記憶媒体は、酸化鉄フイルム、又はコバルトを被着した酸化鉄フイルムと;ネオジウム、鉄を主材とする永久磁石を希塩酸で溶解し、その飽和溶液に対して、ゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を10容量%の比率で混和し、これを120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕し、その粉末の水溶液を浸潤又は塗布して乾燥させたシートと;を貼りあわせたものが好ましい。
【0030】
本発明の方法に使用する前記情報記憶用磁気記憶媒体水は、ネオジウム、鉄、硼酸を主材とする永久磁石を希塩酸で溶解した溶液に、これと等量のゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を混和し、この混合液を120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕した粉末の1%水溶液が好ましい。
【0031】
抗原4を逆情報を逆転写で記憶させた前記媒体5及び/又は抗体6を正転写で記憶させた前記媒体5はそのまま人以外の生物又は生物の環境下に投与してもよいが、セラミック材料に混練し、乾燥・焼成したセラミックス体にしたものを水を介して生物の環境下に投与してもよい。
この場合のセラミックス体には下記の形態がある。
【0032】
第1の形態は、磁石1のN極とS極の対向面間に生成される直線磁場2のN極寄りに、抗原4等又は抗原等の情報を記憶させた磁気記憶媒体を配置するとともに、前記直線磁場2の外側に生成される湾曲磁場3に、媒体5としての情報記憶用磁気記憶媒体水を置き、この磁気記憶媒体水をセラミック材料に混合して乾燥・焼成してなるセラミックス体である。
このセラミックス体は抗原4の逆情報を記憶しているセラミックス体である。
【0033】
第2の形態は、磁石1のN極とS極の対向面間に生成される直線磁場2N極寄りに、抗体6等又は抗体等の情報を記憶させた磁気記憶媒体などの物体を置くとともに、これら物体よりもS極寄りの前記直線磁場2に,媒体5としての情報記憶用磁気記憶媒体水を置き、この磁気記憶媒体水をセラミック材料に混合して乾燥・焼成してなるセラミックス体である。
このセラミックス体は抗体6の正情報を記憶しているセラミックス体である。
【0034】
第3の形態は、磁石1のN極とS極の対向面間に生成される直線磁場2のN極寄りに、抗原4又は抗原の情報を記憶させた磁気記憶媒体を配置するとともに、前記直線磁場2の外側に生成される湾曲磁場3に、媒体5としての情報記憶用磁気記憶媒体水を置き、この磁気記憶媒体水を取りだして、さらに、抗体6又は抗体の情報を記憶させた磁気記憶媒体などの物体を置いた直線磁場2のS極寄りに置いた後、セラミック材料に混合して乾燥・焼成してなるセラミックス体である。
このセラミックス体は抗原4の逆情報と抗体6の正情報を記憶しているセラミックス体である。
【0035】
以下に本発明の実施例を挙げる。
なお、ここに挙げる実験例(実施例1〜6)はいずれも委託試験研究として国立水産大学校生物生産学科防疫学教室の高橋幸則教授により実施されたものである。
【0036】
(実施例1)バキュロウイルス逆情報によるバキュロウイルスの活性制御作用−1
試験方法
約10日程予備飼育した平均体重約12.5gの健全クルマエビ約300尾から、一部を除きバキュロウイルスを強制感染処理をおこなった。この処理、非処理エビからストレスなどによる活性異常のエビ除去の選別をおこない、30尾づつの下記5つの試験区を編成し、約200リットルの各水槽に収容した。
本発明試験区の3群は、バキュロウイルスの情報波動を湾曲磁場4で逆転写した記憶水を使用しもので、
第1試験区はバキュロウイルス逆転写記憶水(逆転水)を飼育槽の飼育水に使用した群
第2試験区はバキュロウイルス逆転写記憶水(逆転水)を噴霧処理した配合飼料ペレットを投与した群
第3試験区は逆転写記憶水で作成したセラミックを用いて処理した飼育水を使用した群
第4試験区はバキュロウイルスを強制感染させた対照群
第5試験区は無処理の健全エビの対照群
である。
【0037】
強制感染方法は、本病によって斃死した体重約10gのクルマエビ3尾の頭胸部の甲皮を剥がしたのち、40mlの滅菌海水中でホモジナイズし、遠心分離(10,000×g、10分間、4℃)によって得られた上澄み1mlを2,000mlの海水に加える比率で環境感染液を調整した。この中に予備飼育中のエビを2時間浸漬して強制感染させた。逆転写記憶水は、この上澄み液を装置の前記直線磁場2のN極寄りに置き、磁石1の湾曲線磁場3に記憶水を配置して作成した。
各区の群編成後、飼育水温22℃のバキュロウイルス活性温度に保ちつつ、10日間の飼育を行い、摂餌状況、斃死状況を観察した。斃死エビについてはPCR法及び病理学的検査を行ってバキュロウイルスによる斃死であることを確認した。
【0038】
試験結果:本発明試験区及び対照区におけるバキュロウイルスによる強制感染後のクルマエビの累積斃死尾数、累積斃死率と各日朝の残餌率を表1に示した。
【表1】

Figure 0004183800
【0039】
表1から明らかなように、バキュロウイルス強制感染後、感染処理群の対照区(第4試験区)のエビは10日以内に壊滅的な斃死をみたのに対し、本発明試験区の斃死率は30〜40%であり、これらの間に有意な差がみられた(p<0.05)。また、無処理の対照区(健全エビ)の斃死率が27%程度であり試験区と有意な差がみられなかった(p<0.05)。すなわち、強制感染群も、本発明の3種の処理によってバキュロウイルスによる急性ウイルス血症を制御し、健全エビとほぼ同じ生残を示したものである。
なお、無処理の対照区(健全エビ)が27%程度斃死したのは予備水槽から試験水槽への移槽によるストレス及び狭い試験水槽のストレスによるものである。
この試験から、クルマエビ体内に侵入したバキュロウイルスが、環境飼育水からバキュロウイルスの活性逆情報と思われる情報を受け、またはバキュロウイルスの活性逆情報と思われる情報を経口的に受け、その活性が低下したことが判明した。しかも、従来の薬剤を使用せずに、情報のみでバキュロウイルスの活性が制御されるという事実が明らかになった。
【0040】
(実施例2)バキュロウイルス逆情報によるバキュロウイルスの活性制御作用−2
試験方法:平均体重11.5gのエビを用い、実施例1と同じ処理を行い下記の5つの試験区を設定した。
第1試験区はバキュロウイルス逆転写記憶水(逆転水)を飼育槽の飼育水に使用した群
第2試験区は逆転写記憶水で作成したセラミックを用いて処理した飼育水を使用し、且つ、バキュロウイルス逆転写記憶水(逆転水)を噴霧処理の配合飼料ベレットを投与した群
第3試験区は直線磁場2にバキュロウイルス記憶済みの磁気記憶媒体を配置し、湾曲磁場3の水を飼育水槽にパイプを介してが常時循環通過させる群
第4試験区はバキュロウイルスを強制感染させた対照群
第5試験区は無処理の健全エビの対照群である。
【0041】
試験結果:本発明試験区及び対照区におけるバキュロウイルス強制感染後のクルマエビの累積斃死尾数、累積斃死率と各日朝の残餌率を表2に示した。
【表2】
Figure 0004183800
【0042】
表2から明らかなように、バキュロウイルス強制感染後、感染処理対照区は9日で100%斃死したのに対し、本発明による試験区3区ともに35%程度であり、対照区との間に有意な差がみられた(p<0.01)。試験区3の結果から、磁化記憶水を使用しなくても、飼育環境水に常時逆転処理を行えばバキュロウイルスの活性を制御できることがわかった。この処理速度は飼育水量1回転/12時間以上である。また、非感染の無処理対照区と本発明試験区との斃死率に有意差はみられなかった。
【0043】
(実施例3)生体防御機能向上情報によるバキュロウイルス活性の制御作用
試験方法:平均体重約12.0gのエビを用い、実施例1と全く同様な処理を行い下記の5つの試験区を設置した。
対照区の2つの区は前記と同様に強制感染処理群との未処理健全群である。
本発明の3つの試験区はバキュロウイルスの逆情報ではなく、生体防御機能向上させる抗体の正情報を利用する区である。あらかじめ、10数尾を別途飼育し、ペプチドグリカン(PG)を適正量、適正期間投与する。この処置によりエビの生体防御機能が増強することが既に確認されている。本試験では、これらのエビ数尾から血液を採取し、遠心分離処理液から磁気装置を用いて記憶水ならびに磁気記憶媒体に転写した。
第1試験区はこの記憶水を噴霧処理した飼料ペレットをクルマエビに投与した群
第2試験区はこの記憶水を用いて作成したセラミックを水槽に浸漬して飼育環境水を処理した群
第3試験区は血液の情報を記憶させた磁気記憶媒体をいったん逆転再転写して新たな磁気記憶媒体を作り、それを磁気装置の直線磁場N極側に配置して、湾曲磁場4の水を飼育水槽にパイプを介してが常時循環通過させる群。このパイプを通過した飼育環境水は生体防御機能増強の血液情報(正)→逆転(負)→再逆転(正)となる。
第4試験区はバキュロウイルスを強制感染させた対照群
第5試験区は無処理の健全エビの対照群である。
【0044】
試験結果:本発明試験区及び対照区におけるバキュロウイルス強制感染後のクルマエビの累積斃死尾数、累積斃死率と各日朝の残餌率を表3に示した。
【表3】
Figure 0004183800
【0045】
表3に示すように、無処理対照区は10日後の斃死率が36.7%にとどまったのに対し、強制感染対照区は96.7%が斃死した。一方、餌に生体防御情報記憶水を噴霧処理した試験区1、同記憶水を用いて作成したセラミックにて飼育水を処理した試験区2、及び、装置を用いて常時飼育水を循環させた試験区3の斃死率は各々40.0%、33.3%、及び33.3%であり、強制感染対照区と有な差が認められた(p<0.05)。
同時に無処理対照区とほぼ同率の斃死率であった。
【0046】
(実施例4)バキュロウイルス逆情報と生体防御機能正情報併用によるバキュロウイルス活性制御作用−その1
試験方法:平均体重約12.5gのエビを用い、実施例1と全く同じ処理を行い5つの試験区を設定した。
本発明試験区は第1試験区〜第4試験区の4つの区で、いずれも、バキュロウイルスの情報を逆転写した記憶媒体と生体防御機能を増強させた血液からその情報を記憶させた記憶媒体を併用した区である。対照区は強制感染処理区のみである。
第1試験区はバキュロウイルス逆情報と生体防御情報の両者を記憶させた記憶水でペレットに噴霧添加処理し給餌する群
第2試験区は第1試験区と同じ2種の情報の記憶水で作成したセラミックを用い、飼育環境水を処理する群
第3試験区は第1試験区と第2試験区の併用区である。
第4試験区は飼育環境水を、2種の情報の記憶媒体を設置した磁気装置に常時循環通過させて、バキュロウイルス逆情報と生体防御情報を飼育環境水に投与する群である。
第5試験区はバキュロウイルスを強制感染させた対照群
【0047】
試験結果:本発明試験区及び対照区におけるバキュロウイルス感染後の累積斃死尾数、累積斃死率及び残餌率(各朝)を表4に示した。
【表4】
Figure 0004183800
【0048】
表4に示すように、バキュロウイルス強制感染後、対照区は10日後には90%以上が斃死した。これに対し、ウイルス性と生体防御の2情報を与えられた餌区とセラミック区はほぼ30%の斃死率、餌とセラミック併用区では20%以下の斃死となった。さらに、2情報を磁気装置を使用して飼育環境水を処理した区は15%以下の斃死率となった。試験区はすべて、対照区と比べ斃死率において有意な差が認められた(p<0.05)。
【0049】
(実施例5)バキュロウイルス逆情報と生体防御機能増強正情報併用によるバキュロウイルス活性制御作用−その2
試験方法:平均体重約14.0gのエビを用い、実施例1と同様の処理を行い5つの試験区を設定した。第1試験区〜第4試験区は本発明2よる試験区であり、対照区は強制感染処理区のみである。
第1試験区はバキュロウイルスの逆情報と生体防御機能増強正情報を併用して作成したセラミックを飼育環境水に使用すると同時に、この両情報記憶水でペレット処理し投与する群(実施例4の試験区3と同じ)
第2試験区はバキュロウイルス逆情報と生体防御機能増強正情報を記憶した磁気記憶媒体とパイプを磁気装置に設置し、常時外気を送りこんで、飼育環境水を曝気する区である。
第3試験区は第2試験区の変形で、送気パイプの中間に水箱をおきその箱の水を曝気した後の空気を飼育環境水に送気して再曝気する区である。なお、この水箱には情報記憶用磁気記憶媒体水を使用した。
第4試験区は第1試験区と第3試験区の併用、すなわち餌処理、セラミックによる飼育環境水処理及び情報記憶用磁気記憶媒体水経由の曝気による飼育環境水処理を行う区である。
【0050】
試験結果:本発明試験区及び対照区におけるバキュロウイルス感染後の累積斃死尾数、累積斃死率及び残餌率(各朝)を表5に示した。
【表5】
Figure 0004183800
【0051】
表5に示すように、バキュロウイルス強制感染後、感染対照区は10日以内に90%以上が斃死したのに対し、餌処理とセラミックによる飼育環境水処理を併用した第1試験区では20%の斃死率であった。曝気により飼育環境水を処理した第2試験区では25%以下の斃死率であった。さらに、送気パイプの中間に人工生体水を設置した第3試験区では10%の斃死率であった。また、餌、セラミック及び情報記憶用磁化水使用の曝気を併用した4試験区では15%以下の斃死率であった。これら本発明試験区のすべてが対照区と比べ、斃死率において有意な差がみられた(p<0.05)。
【0052】
(実施例6)生体防御機能増強剤情報によるバキュロウイルスの活性制御作用
試験方法:平均体重約13.0gのエビを用い、実施例1と全く同様な処理を行い下記の5つの試験区を設定した。対照区は強制感染処理群と未処理健全群の2区である。第1試験区〜第3試験区は本発明の試験区であり、いずれも、生体防御機能増強剤ペプチドグリカンの情報を直接正転写で記憶させたものを利用する区である。また、対照区は強制感染処理群と未処理健全群の2区である。
第1試験区は磁気装置、磁気記憶媒体及び磁気記憶水を使用してペプチドグリカン情報転写液を調整し、それをもってペレットを処理し投与する区
第2試験区はペプチドグリカン情報記憶液を用いてセラミックスを作成し、それを使用して飼育環境水を処理する区
第3試験区はペプチドグリカン情報記憶済みの磁気記憶媒体を配置した磁気装置にパイプを設置し外気を人口生体水通過後飼育環境水に通気する区である。
第4試験区はバキュロウイルスを強制感染させた対照群
第5試験区は無処理の健全エビの対照群である。
【0053】
試験結果:本発明試験区及び対照区におけるバキュロウイルス感染後の累積斃死尾数、累積斃死率及び残餌率(各朝)を表6に示した。
【表6】
Figure 0004183800
【0054】
表6に示すように、バキュロウイルス強制感染対照区は9日後に全滅した。無処理健全区は30%が斃死しその間に有意な差がみられた。試験区は何れも50%程度の斃死率となり感染対照区と有意な差がみられたが、無処理健全区とは有意な差がみられなかった。
【0055】
上記の説明では主としてエビの養殖におけるバキュロウイルス感染症に本発明を応用した実施例を示したが、本発明はこれに限定されるものではなく、ブリのイリドウイルス感染症及び連鎖球菌症、ヒラメのヘルペスウイルス感染症、アユのシュードモナス病及び冷水症、アワビのウイルス性筋萎縮症、ブタのマイコプラズマ症(SEP)、オーエスキー病、生殖器、呼吸器症候群、ニワトリの大腸菌症、マイコプラズマ症(CDR)などの予防や種々の生物のいろいろな疾病の治療に広く応用することができるものである。
【0056】
【効果】
本発明はウイルス等の病原体(抗原)の活性を抑制するための、抗原の逆情報波動、並びに、生物の免疫機能を増強させる抗体の正情報波動を利用して疾病を予防し、治療するので化学薬剤の直接投与を一切用いずに生物を健全に育成することができる。従って、化学薬剤の使用による公衆衛生上の問題が解消される。
【0057】
また、実験例から明らかなように、ウイルスに強制感染させ、放置しておけば数日で100%死滅してしまう生物群が、本発明の方法によれば感染していない生物群と同等の生存率を示すところから、その疾病予防・治療効果は絶大であり、これまでに例を見ないものである。
従って、生物、特に魚介甲殻類の養殖において、著しい経済効果がもたらされる。
【0058】
抗原や抗体の情報波動を記憶させた磁気記憶媒体を使用する場合は、有害な抗原を直接扱う必要がないので安全であり、また、記憶済みの磁気記憶媒体を反復して使用できるので効率がよい。
【図面の簡単な説明】
【図1】 本発明の方法に使用される磁気装置の概略構成図
【図2】 本発明の方法の実施例を示す概略図
【図3】 抗原の情報を記憶させた磁気記憶媒体の生成工程説明図
【図4】 本発明の方法の他の実施例を示す概略図
【図5】 本発明の方法に使用される他の磁気装置の概略構成図
【符号の説明】
1、1a、1b…磁石
2…直線磁場
3…湾曲磁場
4、4a…抗原
4b…抗原の情報を記憶させた磁気記憶媒体
5…媒体
6…抗体
7…曲線磁場
8…外側曲線磁場
9…枠[0001]
[Industrial application fields]
The present invention relates to a disease prevention / treatment method for living organisms that promotes the activity by treating information from antigens and antibodies obtained through magnetism, and an information storage medium and information-stored ceramic body used in this method.
[0002]
[Prior art]
In recent years, with the development of seafood crustacean aquaculture, viral and bacterial diseases frequently occur, causing serious damage. In the case of viral diseases, there has been significant economic damage, particularly due to iridovirus infections such as red sea bream, sea bream, amberjack, yellowtail, and shrimp baculovirus infections, but no therapeutic drugs have been developed yet. . Regarding bacterial infections, the economic damages caused by nodular diseases, vibrio infections, and edwarda infections are significant. Various antibiotics and synthetic antibacterial agents have been used as therapeutic agents for these bacterial diseases, but in recent years, resistant bacteria have emerged against antibiotics, and a sufficient therapeutic effect cannot be obtained. In addition, since there is a problem in public health due to the residual of the drug used in fish and shellfish in the body, prevention of epidemics that does not depend on chemotherapy is strongly desired.
[0003]
On the other hand, techniques for increasing the immune function of seafood shellfish to reduce damage are already known, and some have been put into practical use. As immune function enhancers, there are polysaccharides such as peptide glucan derived from bifidobacteria and β-1,3-glucan derived from mushrooms, and development is ongoing. However, since these drugs administer the drug directly to the organism, the drug is consumed each time, and the cost is high. In addition, direct administration of a drug does not only provide a sufficient preventive / therapeutic effect, but also has many adverse effects caused by abuse or misuse.
[0004]
[Problems to be solved by the invention]
As described above, many diseases have occurred in the cultivation of seafood shellfish, and the damage caused by this has reached 25 billion yen in Japan alone. Not only economic damage, but also sound management based on aquaculture technology such as seed production, compound feed, breeding management and aquaculture facility equipment that has been accumulated over many years due to illness greatly fluctuated from the bottom, even the survival of the industry It is the current time that is in danger. The reasons for this include the emergence of resistant bacteria due to misuse of drugs, the development of chemical drugs and vaccines that cannot keep up with the occurrence of new viruses, the stress of environmental degradation and high-density production, and the decline in immune function.
[0005]
In terms of the growth of seafood shellfish, cultivating fisheries and marine ranch projects are being promoted as national measures aimed at restoring depleted resources. However, there have been frequent cases of artificial hatching mass-produced seedlings and discharge juveniles that form the basis of this project that have been infected with viruses and bacteria before release. If even a small part of a large number of juveniles is infected, it is impossible to discharge the whole because it is functionally difficult to perform biopsy and identification of the infection, and it will be discarded. This is because, compared to aquaculture that can be managed after the fact, it cannot be managed by breeding, and it is not allowed to release the plague to nature.
[0006]
Therefore, the first object of the present invention is to reduce the antigenic activity of living organisms and enhance immune function without direct administration of drugs or vaccines, thereby to make living organisms, particularly seafood crustaceans healthy and safe. It is to provide a method for preventing and treating diseases of living organisms.
[0007]
The second object of the present invention is to provide a magnetic storage medium and magnetized water for information storage used in the above disease prevention / treatment methods.
[0008]
A third object of the present invention is to provide a ceramic body of an information storage medium used for the above disease prevention / treatment method.
[0008]
[Means for Solving the Problems]
In order to achieve the first object, the first disease prevention / treatment method according to the present invention comprises: Has the magnetic force necessary to store material information in a magnetic storage medium A magnetic storage medium storing a pathogen, a foreign substance for a living body, an antigen or the like or information thereof is arranged near the north pole of the linear magnetic field generated between the N and S poles of the magnet. Magnetic storage medium in a curved magnetic field generated outside the magnetic field After placing , A medium of the bending magnetic field or a substance containing the medium Take out non-human It is characterized by being administered in a living organism or a living environment.
[0009]
The second disease prevention / treatment method according to the present invention comprises: Has the magnetic force necessary to store material information in a magnetic storage medium Activated leukocytes and other cells, antibodies, biological defense function enhancers, or magnetic memory storing these information in the vicinity of the north pole of the linear magnetic field generated between the opposing faces of the north and south poles of the magnet While placing an object such as a medium, the magnetic storage medium is placed in the linear magnetic field closer to the S pole than these objects. After placing The medium placed near the S pole of the linear magnetic field or a substance containing the medium Take out non-human It is characterized by being administered in a living organism or a living environment.
[0010]
A third disease prevention / treatment method according to the present invention is characterized by performing the above two methods in combination.
[0011]
the above Disease prevention and treatment The magnetic storage medium for information storage used in the method is an iron oxide film or an iron oxide film coated with cobalt; and a saturated solution in which a permanent magnet mainly composed of neodymium and iron is dissolved in dilute hydrochloric acid. A 1% dilactyl dilactate 1% solution is mixed at a ratio of 10% by volume, dried and crystallized at 120 ° C. or lower, magnetized, then pulverized, infiltrated with an aqueous solution of the powder, and dried. And are preferably bonded together.
[0012]
Also, above Disease prevention and treatment For information storage used in the method Magnetic storage media Is mixed with a solution of a permanent magnet mainly composed of neodymium, iron and boric acid in dilute hydrochloric acid, and an equivalent amount of 1% sodium dilactyl germanate solution is mixed with this solution and dried at 120 ° C. or lower. 1% aqueous solution of powder that has been crystallized, magnetized and then pulverized Magnetic storage medium water for information storage Is preferred.
[0013]
The above information is stored Magnetic storage medium water The medium such as this as it is Non-human It may be used by being administered in a living organism or an environment of a living organism, but it may be used as a ceramic body diluted with water, kneaded into a ceramic material, dried and fired.
[0014]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings.
Substances such as elements, compounds, life forms, antigens, and antibodies each have a unique wavelength waveform. Therefore, information on these substances is stored in magnetic storage media. To the body The present invention has been made by repeating various experiments under the idea that if it can be stored (transferred) and reproduced, it can be used for various useful purposes.
[0015]
For this invention, first, a magnetic device as shown in FIG. 1 was prepared in order to store information on a substance in a magnetic storage medium using strong magnetism.
This device uses a permanent magnet 1 such as a horseshoe magnet in which the N pole and the S pole are opposed to each other with a predetermined interval. From the N pole to the S pole of the magnet 1, the N pole is changed to the S pole. A linear magnetic field 2 in which the magnetic lines of force are directed straight is generated.
In addition, a curved magnetic field 3 is generated outside the linear magnetic field 2 and the magnetic field lines are curved from the N pole toward the S pole.
[0016]
Various experiments were performed using the apparatus shown in FIG.
First, as Experiment 1, an aquatic product such as shrimp infected with a virus is placed near the north pole of the linear magnetic field 2, and the magnetic storage medium is placed near the south pole. Magnetic storage medium water Put. After about 60 seconds Magnetic storage medium water When (memory water) was taken out and put into the breeding water of virus-infected shrimp, it died earlier than virus-infected shrimp in normal breeding water.
[0017]
On the other hand, in Experiment 2, a blood cell collected from shrimp blood whose biological defense function was enhanced with a biological defense (immunity) enhancer was placed near the north pole of the linear magnetic field 2 and magnetized near the south pole of the linear magnetic field 2. As a storage medium Magnetic storage medium water After about 60 seconds Magnetic storage medium water When (memory water) was taken out and placed in the breeding water of virus-infected shrimp, the survival rate was equivalent to that of normal shrimp in normal breeding water.
[0018]
This means that if an antigen or antibody is placed near the north pole of the linear magnetic field 2 and a magnetic storage medium is placed near the south pole, the unique information possessed by the antigen or antibody is stored in the magnetic storage medium as a positive transfer. Moreover, it is considered that the information stored in the storage medium is reproduced in the breeding tank and acts on the shrimp in the breeding tank.
[0019]
However, as an experiment 3 related to the experiment 1, an aquatic product such as shrimp infected with a virus is placed near the north pole of the linear magnetic field 2 and a curved magnetic field 3 generated outside the linear magnetic field 2 of the magnet 1. Magnetic storage media Body After about 60 seconds, when this medium was put into the breeding water of virus-infected shrimp, as in Experiment 2, the survival rate was the same as that of normal shrimp in normal breeding water.
[0020]
Further, only the storage medium storing the antigen of the living organism and the information of this antigen is placed near the N pole of the linear magnetic field 2, and the magnetic storage medium is stored in the bending magnetic field 3 as described above. Body When this storage medium was placed in the breeding water of virus-infected shrimps, the survival rate was the same as that of normal shrimps, as in Experiment 2.
[0021]
This is because a magnetic storage medium storing an antigen of an organism or antigen information is placed near the north pole of the linear magnetic field 2, and the magnetic storage medium is placed in the curved magnetic field 3 outside the linear magnetic field 2. Body Put it in the curved magnetic field 3 Magnetic storage medium water In a medium such as the above, information against the antigen (hereinafter referred to as reverse information) is stored as reverse transcription, that is, stored as information having an antiviral function and reproduced in a shrimp breeding environment. Conceivable.
[0022]
Next, embodiments of the present invention will be illustrated.
In the first embodiment, as shown in FIG. 2, a pathogen such as a virus, a life form having a pathogen, or a magnetic storage medium (hereinafter referred to as “antigen 4”) in which such information is stored near the north pole of the linear magnetic field 2. And a magnetic storage medium in the bending magnetic field 3 Body 5 For about 60 seconds. By doing so, the information of the antigen 4 is reversely transferred to the medium 5 of the bending magnetic field 3, and the medium 5 becomes a substance having information having a resistance to the antigen 4.
Thus, the disease caused by the pathogen of the organism can be prevented by mixing this substance with the feed of the organism and administering it, adding it to ceramics and putting it into the breeding tank, or using it as breeding water in the breeding tank. Healed.
[0023]
In the above-described embodiment, it is more preferable to use a magnetic storage medium in which information on the antigen is stored as the antigen placed near the north pole of the linear magnetic field 2 than to use the antigen itself. This is because antigens are generally harmful and are safe to use in the form of storage media rather than being handled directly.
As shown in FIG. 3, the magnetic storage medium in which such information is stored has a natural antigen 4a such as a virus or pathogen placed near the north pole of the linear magnetic field 2, and the magnetic storage medium 4b is placed on the south pole side. Can be generated by placing. That is, the information on the raw antigen 4a is transferred to the magnetic storage medium 4b in the linear magnetic field 2 to obtain the magnetic storage medium 4b in which the information on the raw antigen 4a is stored.
[0024]
In the second embodiment of the present invention, as shown in FIG. 4, the biological defense function enhancer or the biological tissue in which the biological defense function is enhanced near the north pole of the linear magnetic field 2 of the magnet 1, or these substances A magnetic storage medium in which an object such as a magnetic storage medium (hereinafter referred to as antibody 6) that stores the information is placed in the linear magnetic field 2 closer to the S pole than the antibody 6 is stored. Body 5 For about 10-60 seconds. After that, the medium 5 is treated in the same manner as described above. Non-human It is administered in a living organism or living environment.
That is, in this embodiment, the information on enhancing the biological defense function is stored in the magnetic field in the linear magnetic field 2. To the body Positive transfer.
[0025]
In this case as well, the antibody 6 itself such as a biological defense function enhancer or a biological tissue with enhanced biological defense function may be directly placed near the north pole of the linear magnetic field 2, but preferably the information of the antibody 6 is forward-transcribed. A magnetic storage medium stored in (1) may be placed. This magnetic storage medium is obtained by placing the antibody 6 near the north pole of the linear magnetic field 2 of the magnetic device and placing the magnetic storage medium near the south pole in the same manner as in FIG. The magnetic storage medium stores information on the antibody 6.
[0026]
The magnet apparatus shown in FIGS. 1 to 4 shows a preferable example used in the method of the present invention, and the present invention is not limited to this. For example, as shown in FIG. 5, a pair of left and right magnets 1a and 1b are arranged so that their north and south poles face each other at a predetermined interval, and a straight line is formed between the opposing faces of the opposite north and south poles. It is also possible to use a magnet device in which a magnetic field 2 is generated and a curved magnetic field 3 along the linear magnetic field 2 is generated outside the linear magnetic field 2.
[0027]
5 further generates a curved magnetic field 7 from the north pole of each magnet 1a, 1b to the south pole, and a curved magnetic field 3 from the north pole of the magnet 1a to the south pole of the magnet 1b. However, the region where the medium 5 for reverse transfer is placed is the curved magnetic field 3 from the N pole of the magnet 1a toward the S pole of the magnet 1b.
In the apparatus of FIG. 5, the linear magnetic field 2, the curved magnetic field 3, and the outer curved magnetic field 8 are partitioned by a frame 9.
[0028]
When the apparatus of FIG. 5 is used, when taking out the stored medium of the linear magnetic field 2, it is necessary to remove the magnets 1 a and 1 b so as not to be affected by the outer curved magnetic field 8. For the same reason, in order to take out the medium of the bending magnetic field 3 to which the information of the antigen 4 is reversely transferred, it is necessary to remove the magnets 1a and 1b or to take out from the direction opposite to the direction of the magnetic field of the bending magnetic field 3.
[0029]
The magnetic storage medium for information storage used in the method of the present invention is an iron oxide film or an iron oxide film coated with cobalt; a permanent magnet mainly composed of neodymium and iron is dissolved in diluted hydrochloric acid, and a saturated solution thereof On the other hand, 1% solution of dilactyl digermanate 2% sodium lactate is mixed in a ratio of 10% by volume, dried and crystallized at 120 ° C. or less, magnetized, and pulverized. A sheet obtained by laminating a sheet which has been infiltrated or coated and dried is preferable.
[0030]
For the information storage used in the method of the present invention Magnetic storage medium water Is mixed with a solution of a permanent magnet mainly composed of neodymium, iron and boric acid in dilute hydrochloric acid, and an equivalent amount of 1% sodium dilactyl germanate solution is mixed with this solution and dried at 120 ° C. or lower. A 1% aqueous solution of powder that has been crystallized and magnetized and then ground is preferred.
[0031]
The medium 5 in which the antigen 4 is stored by reverse transcription and / or the medium 5 in which the antibody 6 is stored by forward transcription is used as it is. Non-human Although it may be administered in a living organism or a living environment, a ceramic body kneaded in a ceramic material, dried and fired may be administered in a living environment via water.
The ceramic body in this case has the following forms.
[0032]
In the first form, a magnetic storage medium in which information such as antigen 4 or information such as antigen is stored is arranged near the north pole of the linear magnetic field 2 generated between the N pole and S pole facing surfaces of the magnet 1. For storing information as the medium 5 in the bending magnetic field 3 generated outside the linear magnetic field 2 Magnetic storage medium water Put this Magnetic storage medium water Is a ceramic body obtained by mixing and drying the ceramic material.
This ceramic body is a ceramic body that stores the reverse information of the antigen 4.
[0033]
In the second mode, an object such as a magnetic storage medium storing information such as antibody 6 or the antibody is placed near the linear magnetic field 2N pole generated between the N pole and S pole facing surfaces of the magnet 1. For storing information as the medium 5 in the linear magnetic field 2 closer to the S pole than these objects Magnetic storage medium water Put this Magnetic storage medium water Is a ceramic body obtained by mixing and drying the ceramic material.
This ceramic body is a ceramic body that stores positive information of the antibody 6.
[0034]
In the third embodiment, the magnetic storage medium storing the antigen 4 or the antigen information is arranged near the north pole of the linear magnetic field 2 generated between the facing surfaces of the north and south poles of the magnet 1. For information storage as a medium 5 in a bending magnetic field 3 generated outside the linear magnetic field 2 Magnetic storage medium water Put this Magnetic storage medium water The ceramic is obtained by placing it near the south pole of the linear magnetic field 2 on which an object such as the magnetic storage medium storing the antibody 6 or antibody information is placed, and then mixing and drying and firing the ceramic material. Is the body.
This ceramic body is a ceramic body that stores the reverse information of the antigen 4 and the positive information of the antibody 6.
[0035]
Examples of the present invention will be given below.
In addition, all of the experimental examples (Examples 1 to 6) listed here were conducted by Prof. Yukinori Takahashi of the National Fisheries University Department of Bioproduction, Department of Epidemiology, as a commissioned test study.
[0036]
(Example 1) Activity control action of baculovirus by baculovirus reverse information-1
Test method
For about 10 days, baculovirus was forcibly infected from about 300 healthy prawns with an average weight of about 12.5 g, which were preliminarily raised for about 10 days. From this treated and untreated shrimp, selection was made to remove shrimp with abnormal activity due to stress, etc., and the following five test zones of 30 fish were organized and accommodated in each 200 liter water tank.
The three groups of the present invention test area use memory water obtained by reverse transcription of the information wave of baculovirus with a curved magnetic field 4.
The first test group is a group using baculovirus reverse transcription memory water (reversed water) for breeding water in the breeding tank
The second test group was a group administered with mixed feed pellets sprayed with baculovirus reverse transcription memory water (reverse water)
The third test group is a group using breeding water treated with ceramics made with reverse transcription memory water
The fourth test group is a control group forcibly infected with baculovirus.
The 5th test zone is an untreated healthy shrimp control group
It is.
[0037]
The forced infection method consists of peeling the crust of the cranio-thoracic region of three crawfish prawns that weighed about 10 g, and homogenized in 40 ml of sterile seawater, followed by centrifugation (10,000 × g, 10 min, 4 min. The environmental infectious solution was adjusted at a ratio of 1 ml of the supernatant obtained at ℃) to 2,000 ml of seawater. The shrimp during the pre-breeding were immersed in this for 2 hours to force infection. The reverse transfer storage water was prepared by placing the supernatant near the north pole of the linear magnetic field 2 of the apparatus and placing the storage water in the curved linear magnetic field 3 of the magnet 1.
After group formation in each ward, the animals were reared for 10 days while maintaining the baculovirus activation temperature at a rearing water temperature of 22 ° C., and the feeding and moribund conditions were observed. The moribund shrimp was confirmed to be moribund by baculovirus by PCR and pathological examination.
[0038]
Test results: Table 1 shows the cumulative number of dead prawns, the cumulative drowning rate, and the daily remaining food rate of each morning prawn after forced infection with baculovirus in the test group and the control group of the present invention.
[Table 1]
Figure 0004183800
[0039]
As is clear from Table 1, the shrimp in the control group (4th test group) of the infection-treated group after catastrophic infection with baculovirus showed devastating death within 10 days, whereas the mortality rate in the test group of the present invention Was 30-40%, with a significant difference between them (p <0.05). Moreover, the mortality rate of the untreated control group (healthy shrimp) was about 27%, and no significant difference was observed with the test group (p <0.05). That is, the forced infection group also controlled the acute viremia caused by the baculovirus by the three treatments of the present invention, and showed almost the same survival as the healthy shrimp.
In addition, about 27% of untreated control plots (healthy shrimp) were drowned due to the stress caused by the transfer from the reserve tank to the test tank and the stress of the narrow test tank.
From this test, baculovirus that invaded the prawns received information that seems to be the reverse information of baculovirus activity from the environment breeding water or the information that seems to be the reverse information of baculovirus activity orally. It turned out that it fell. Moreover, the fact that baculovirus activity is controlled only by information without using conventional drugs has been revealed.
[0040]
(Example 2) Activity control action of baculovirus by baculovirus reverse information-2
Test method: Using shrimp having an average body weight of 11.5 g, the same treatment as in Example 1 was performed to set the following five test sections.
The first test group is a group using baculovirus reverse transcription memory water (reversed water) for breeding water in the breeding tank
The second test group was a group in which breeding water treated with ceramic prepared with reverse transcription memory water was used, and baculovirus reverse transcription memory water (reversal water) was sprayed with a mixed feed beret.
The third test group is a group in which a magnetic storage medium in which a baculovirus is stored is arranged in the linear magnetic field 2 and the water of the curved magnetic field 3 is constantly circulated through a breeding tank through a pipe.
The fourth test group is a control group forcibly infected with baculovirus.
The fifth test zone is an untreated healthy shrimp control group.
[0041]
Test results: Table 2 shows the cumulative number of dead prawns, the cumulative drowning rate of the prawns after the baculovirus forced infection in the test group of the present invention and the control group, and the remaining food rate in the morning of each day.
[Table 2]
Figure 0004183800
[0042]
As is apparent from Table 2, after the baculovirus forced infection, the infection control treatment group died 100% in 9 days, whereas the test group 3 according to the present invention was about 35%, There was a significant difference (p <0.01). From the results of the test group 3, it was found that the activity of baculovirus can be controlled by constantly reversing the breeding environment water without using magnetized memory water. This treatment speed is 1 rotation / 12 hours or more of breeding water. In addition, there was no significant difference in the mortality rate between the uninfected untreated control group and the test group of the present invention.
[0043]
(Example 3) Control action of baculovirus activity by biological defense function improvement information
Test method: Using shrimp having an average weight of about 12.0 g, the same treatment as in Example 1 was performed, and the following five test sections were set up.
The two wards of the control ward are untreated healthy groups with the forced infection treatment group as described above.
Three test groups of the present invention are groups using not the reverse information of baculovirus but the normal information of the antibody that improves the biological defense function. Ten or more fish are raised separately in advance, and peptidoglycan (PG) is administered in an appropriate amount for an appropriate period. It has already been confirmed that this treatment enhances the shrimp's defense function. In this test, blood was collected from several of these shrimps and transferred from the centrifugally treated solution to storage water and magnetic storage medium using a magnetic device.
The first test group was a group in which the feed pellets sprayed with this memory water were administered to prawns
The second test group is a group that treated the breeding environment water by immersing the ceramic created using the stored water in the aquarium.
Third test Ward A magnetic storage medium in which blood information is stored is reversely retransferred to create a new magnetic storage medium, which is placed on the linear magnetic field N pole side of the magnetic device, and the water of the curved magnetic field 4 is piped to the breeding aquarium A group that always circulates through. The breeding environment water that has passed through this pipe is changed to blood information (positive) → reverse (negative) → re-reverse (positive) for enhancing the biological defense function.
The fourth test group is a control group forcibly infected with baculovirus.
The fifth test zone is an untreated healthy shrimp control group.
[0044]
Test results: Table 3 shows the cumulative number of dead prawn tails, the cumulative drowning rate of the prawns after the baculovirus forced infection in the test group of the present invention and the control group, and the remaining food rate in the morning of each day.
[Table 3]
Figure 0004183800
[0045]
As shown in Table 3, in the untreated control group, the death rate after 10 days was only 36.7%, whereas in the forced infection control group, 96.7% died. On the other hand, test group 1 in which biological defense information storage water was sprayed on food, test group 2 in which breeding water was treated with ceramic made using the storage water, and breeding water was circulated constantly using the device. The mortality rate in test group 3 was 40.0%, 33.3%, and 33.3%, respectively. Intention Difference was observed (p <0.05).
At the same time, the death rate was almost the same as the untreated control.
[0046]
(Example 4) Baculovirus activity control action by combined use of baculovirus reverse information and biological defense function positive information-part 1
Test method: Using shrimp having an average body weight of about 12.5 g, exactly the same treatment as in Example 1 was performed to set five test sections.
The test group of the present invention is divided into four sections, the first test section to the fourth test section, all of which have a storage medium that reversely transcribes baculovirus information and a memory that stores the information from blood with enhanced biological defense functions. It is a ward that uses a medium together. The control group is only the compulsory infection treatment group.
The first test group is a group that sprays and feeds pellets with stored water in which both baculovirus reverse information and biological defense information are stored.
The second test zone is a group that treats the breeding environment water using ceramics made from the same two types of memory as the first test zone.
3rd test zone Is the first This is a combination of 1 test zone and 2nd test zone.
The fourth test zone is a group in which the breeding environment water is constantly circulated through a magnetic device in which two kinds of information storage media are installed, and baculovirus reverse information and biological defense information are administered to the breeding environment water.
The fifth test group is a control group forcibly infected with baculovirus.
[0047]
Test results: Table 4 shows the number of cumulative moribund tails, cumulative mortality and residual food rate (each morning) after baculovirus infection in the test group of the present invention and the control group.
[Table 4]
Figure 0004183800
[0048]
As shown in Table 4, after baculovirus forced infection, more than 90% of the control group died after 10 days. On the other hand, the bait and ceramic groups, which were given two information on virality and biological defense, had a mortality rate of approximately 30%, and the bait and ceramic combination group had a mortality rate of 20% or less. Furthermore, the ward death rate of 15% or less was obtained in the section where the breeding environment water was processed using the magnetic device for the two pieces of information. All test groups showed a significant difference in mortality compared to the control group (p <0.05).
[0049]
(Example 5) Baculovirus activity control action by combined use of reverse information of baculovirus and positive information enhancing biological defense function-Part 2
Test method: Using shrimp having an average body weight of about 14.0 g, the same treatment as in Example 1 was performed to set five test sections. The first test group to the fourth test group are test groups according to the present invention 2, and the control group is only the forced infection treatment group.
In the first test group, the ceramic prepared by combining the reverse information of baculovirus and the positive information on the enhancement of biological defense function is used for breeding environment water, and at the same time, the pellet is treated with both information storage waters and administered (Example 4). (Same as Test Zone 3)
The second test section is a section in which a magnetic storage medium and pipes storing baculovirus reverse information and biological defense function enhancement positive information are installed in a magnetic device, and outside air is constantly sent to aerate the breeding environment water.
The third test zone is a modification of the second test zone, in which a water box is placed in the middle of the air supply pipe and the air after the water in the box is aerated is sent to the breeding environment water and re-aerated. This water box is for information storage. Magnetic storage medium water It was used.
The 4th test zone is a combination of the 1st test zone and the 3rd test zone, that is, for food treatment, breeding environment water treatment with ceramics and information storage. Magnetic storage medium water It is a ward where the breeding environment water treatment is performed by aeration.
[0050]
Test results: Table 5 shows the number of cumulative moribund tails, cumulative mortality and residual food rate (each morning) after baculovirus infection in the test group of the present invention and the control group.
[Table 5]
Figure 0004183800
[0051]
As shown in Table 5, after baculovirus forced infection, 90% or more of the infected control group died within 10 days, whereas 20% in the first test group that used both the bait treatment and the ceramic environmental water treatment. The drowning rate. The mortality rate was 25% or less in the second test area where the breeding environment water was treated by aeration. Furthermore, the mortality rate was 10% in the third test section in which artificial biological water was installed in the middle of the air supply pipe. In addition, the mortality rate was 15% or less in the four test sections combined with aeration using bait, ceramic, and magnetized water for information storage. All of the test groups of the present invention showed a significant difference in the mortality rate compared with the control group (p <0.05).
[0052]
(Example 6) Activity control action of baculovirus by information on biological defense function enhancer
Test method: Using shrimp having an average body weight of about 13.0 g, the same treatment as in Example 1 was performed to set the following five test sections. There are two control zones: the forced infection treatment group and the untreated healthy group. The first test group to the third test group are the test groups of the present invention, and all of them use the information obtained by directly storing the information on the biological defense function enhancer peptidoglycan by the positive transcription. In addition, the control group has two groups, a forced infection treatment group and an untreated healthy group.
In the first test section, a peptidoglycan information transfer solution is prepared using a magnetic device, a magnetic storage medium, and magnetic storage water, and the pellet is processed and administered therewith.
In the second test section, ceramics were prepared using peptidoglycan information storage solution, and it was used to treat the breeding environment water.
The third test section is a section in which a pipe is installed in a magnetic device in which a magnetic storage medium in which peptidoglycan information has been stored is arranged, and the outside air is ventilated to the breeding environment water after passing the artificial water.
The fourth test group is a control group forcibly infected with baculovirus.
The fifth test zone is an untreated healthy shrimp control group.
[0053]
Test results: Table 6 shows the number of cumulative moribund tails, cumulative mortality and remaining food rate (each morning) after baculovirus infection in the test group of the present invention and the control group.
[Table 6]
Figure 0004183800
[0054]
As shown in Table 6, the baculovirus-infected control group was annihilated after 9 days. In the untreated healthy area, 30% drowned and there was a significant difference between them. All the test plots had a mortality rate of about 50%, showing a significant difference from the infected control plot, but no significant difference from the untreated healthy plot.
[0055]
In the above description, an example in which the present invention is applied mainly to baculovirus infection in shrimp culture has been shown, but the present invention is not limited thereto, and yellowtail iridovirus infection, streptococcal disease, flounder Herpesvirus infection, ayu pseudomonas disease and cold water disease, abalone viral muscle atrophy, porcine mycoplasmosis (SEP), Aujeszky's disease, genital organs, respiratory syndrome, chicken colibacillosis, mycoplasmosis (CDR) It can be widely applied to prevention and treatment of various diseases of various organisms.
[0056]
【effect】
Since the present invention uses the reverse information wave of antigen to suppress the activity of a pathogen (antigen) such as a virus and the positive information wave of an antibody that enhances the immune function of a living organism to prevent and treat a disease. It is possible to grow a living organism without using any direct administration of chemical agents. Therefore, public health problems due to the use of chemical agents are eliminated.
[0057]
In addition, as is clear from the experimental examples, a group of organisms that are forcibly infected with a virus and die 100% in a few days if left untreated are equivalent to a group of organisms that are not infected according to the method of the present invention. Because of its survival rate, its disease prevention and treatment effects are tremendous, and it has never been seen before.
Therefore, a significant economic effect is brought about in the cultivation of living organisms, particularly fish and shellfish.
[0058]
When using a magnetic storage medium that stores information waves of antigens and antibodies, it is safe because there is no need to handle harmful antigens directly, and it is efficient because the stored magnetic storage medium can be used repeatedly. Good.
[Brief description of the drawings]
FIG. 1 is a schematic configuration diagram of a magnetic device used in the method of the present invention.
FIG. 2 is a schematic diagram showing an embodiment of the method of the present invention.
FIG. 3 is an explanatory diagram of a production process of a magnetic storage medium storing antigen information.
FIG. 4 is a schematic diagram showing another embodiment of the method of the present invention.
FIG. 5 is a schematic configuration diagram of another magnetic device used in the method of the present invention.
[Explanation of symbols]
1, 1a, 1b ... Magnet
2 ... Linear magnetic field
3 ... Bending magnetic field
4, 4a ... antigen
4b: Magnetic storage medium storing antigen information
5 ... Medium
6 ... Antibodies
7… Curve magnetic field
8 ... Outer curve magnetic field
9 ... Frame

Claims (9)

物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場のN極寄りに、病原体、生体にとっての異物、抗原等又はこれらの情報を記憶させた磁気記憶媒体を配置するとともに、前記直線磁場の外側に生成される湾曲磁場に磁気記憶媒体を置いた後、前記湾曲磁場の媒体又はこの媒体を含む物質を取出して人以外の生物又は生物の飼育環境下に投与することを特徴とする人体を除く生物の疾病予防・治療方法Close to the north pole of the linear magnetic field generated between the opposing faces of the north and south poles of the magnet having the magnetic force necessary to store the substance information in the magnetic storage medium, A magnetic storage medium storing these pieces of information is arranged , and after placing the magnetic storage medium in a curved magnetic field generated outside the linear magnetic field, the curved magnetic field medium or a substance containing the medium is taken out and a person is removed. Disease prevention / treatment methods for organisms other than the human body, characterized by being administered in an organism other than the above or in an animal breeding environment 物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場のN極寄りに、活性化された白血球その他の細胞、抗体、生体防御機能増強剤又はこれらの情報を記憶させた磁気記憶媒体などの物体を置くとともに、これら物体よりもS極寄りの前記直線磁場に磁気記憶媒体を置いた後、前記直線磁場のS極寄りに置いた前記媒体又はこの媒体を含む物質を取出して人以外の生物又は生物の飼育環境下に投与することを特徴とする人体を除く生物の疾病予防・治療方法Activated leukocytes and other cells and antibodies near the north pole of the linear magnetic field generated between the opposing faces of the north and south poles of the magnet having the magnetic force necessary to store the substance information in the magnetic storage medium An object such as a biological defense function enhancer or a magnetic storage medium storing these pieces of information is placed, and after placing the magnetic storage medium in the linear magnetic field closer to the S pole than these objects, the S pole of the linear magnetic field A method for preventing or treating a disease of a living organism other than a human body, characterized in that the medium placed close to the medium or a substance containing the medium is taken out and administered to a living organism other than a human or a living environment of the living organism. 請求項1記載の前記湾曲磁場に置いた前記媒体又はこの媒体を含む物質と、請求項2記載の前記直線磁場のS極寄りに置いた前記媒体又はこの媒体を含む物質を、人以外の生物又は生物の飼育環境下に同時に投与することを特徴とする人体を除く生物の疾病予防・治療方法A material containing the medium or the medium was placed in the curved magnetic field of claim 1, wherein the material comprising the medium or the medium were placed in S-pole side of the said linear magnetic field according to claim 2, the non-human organism Or a disease prevention / treatment method for living organisms other than the human body, characterized by being administered simultaneously in the living environment of the living organism 前記直線磁場のN極寄りに置く磁気記憶媒体が、酸化鉄フイルム、又はコバルトを被着した酸化鉄フイルムと;ネオジウム、鉄を主材とする永久磁石を希塩酸で溶解し、その飽和溶液に対して、ゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を10容量%の比率で混和し、これを120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕し、その粉末の水溶液を浸潤又は塗布して乾燥させたシートと;を貼りあわせてなり、前記湾曲磁場又は前記直線磁場S極寄りに置く磁気記憶媒体が、ネオジウム、鉄、硼酸を主材とする永久磁石を希塩酸で溶解した溶液に、これと等量のゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を混和し、この混合液を120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕した粉末の1%水溶液であることを特徴とする請求項1、2、3記載の人体を除く生物の疾病予防・治療方法The magnetic storage medium placed near the north pole of the linear magnetic field is an iron oxide film or an iron oxide film coated with cobalt; a permanent magnet mainly composed of neodymium and iron is dissolved in dilute hydrochloric acid, and the saturated solution Then, 1% solution of dilactyl germanate 2% sodium lactate is mixed at a ratio of 10% by volume, dried and crystallized at 120 ° C. or lower, magnetized and then pulverized, and the aqueous solution of the powder is infiltrated or And a magnetic storage medium placed near the curved magnetic field or the linear magnetic field S pole, in which a permanent magnet mainly composed of neodymium, iron, or boric acid is dissolved in dilute hydrochloric acid. 1% aqueous solution of dilactylgermanate dilactylate and 1% sodium lactate solution mixed with this, dried and crystallized at 120 ° C. or less to magnetize the crystal, and then pulverized powder Biological method of disease prevention and treatment, except the human body according to claim 1, 2, 3, wherein a is 酸化鉄フイルム、又はコバルトを被着した酸化鉄フイルムと;ネオジウム、鉄を主材とする永久磁石を希塩酸で溶解した飽和溶液に対して、ゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を10容量%の比率で混和し、これを120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕し、その粉末の水溶液を浸潤させて乾燥したシートと;を貼りあわせてなることを特徴とする生命体の情報記憶用磁気記憶媒体Iron oxide film or iron oxide film coated with cobalt; 10% by volume of 1% solution of dilactyl dilactate 2% sodium lactate in a saturated solution in which a permanent magnet mainly composed of neodymium and iron is dissolved in dilute hydrochloric acid It is mixed at a ratio, dried and crystallized at 120 ° C. or less, magnetized, then pulverized, infiltrated with an aqueous solution of the powder, and a dried sheet; Magnetic storage media for information storage of life forms ネオジウム、鉄、硼酸を主材とする永久磁石を希塩酸で溶解した溶液に、これと等量のゲルマン酸ジラクチル2乳酸ナトリウム1%溶液を混和し、この混合液を120℃以下で乾燥・結晶させてその結晶体を着磁したのち粉砕した粉末の1%水溶液であることを特徴とする生命体の情報記憶用磁気記憶媒体水 A permanent magnet mainly composed of neodymium, iron, and boric acid is dissolved in dilute hydrochloric acid and mixed with an equal amount of 1% dilactyl germanate dilactate solution. The mixture is dried and crystallized at 120 ° C or lower. Magnetic storage medium water for information storage of living organisms, characterized in that it is a 1% aqueous solution of powder that has been magnetized and then pulverized 物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場のN極寄りに、病原体、生体にとっての異物、抗原等又はこれらの情報を記憶させた磁気記憶媒体を配置するとともに、前記直線磁場の外側に生成される湾曲磁場に、情報記憶用磁気記憶媒体水を置き、この磁気記憶媒体水をセラミック材料に混合して乾燥・焼成してなる情報記憶済みセラミックス体Close to the north pole of the linear magnetic field generated between the opposing faces of the north and south poles of the magnet having the magnetic force necessary to store the substance information in the magnetic storage medium, The magnetic storage medium storing these pieces of information is arranged, and the magnetic storage medium water for information storage is placed in the curved magnetic field generated outside the linear magnetic field, and the magnetic storage medium water is mixed with the ceramic material. Information-stored ceramic body dried and fired 物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場N極寄りに、活性化された白血球その他の細胞、抗体、生体防御機能増強剤又はこれらの情報を記憶させた磁気記憶媒体などの物体を置くとともに、これら物体よりもS極寄りの前記直線磁場に情報記憶用磁気記憶媒体水を置き、この磁気記憶媒体水をセラミック材料に混合して乾燥・焼成してなる情報記憶済みセラミックス体Activated leukocytes and other cells, antibodies, near the linear magnetic field N pole generated between the opposing faces of the N pole and S pole of the magnet having the magnetic force necessary to store the substance information in the magnetic storage medium , with placing an object such as a magnetic storage medium storing biological defense function enhancers or their information, placing the linear magnetic field in the information storing magnetic storage medium water S poles nearer these objects, the magnetic storage medium water Information-stored ceramic body made by mixing and drying and firing ceramic materials 物質の情報を磁気記憶媒体に記憶させるのに必要な磁力を有する磁石のN極とS極の対向面間に生成される直線磁場のN極寄りに、病原体、生体にとっての異物、抗原等又はこれらの情報を記憶させた磁気記憶媒体を配置するとともに、前記直線磁場の外側の湾曲磁場に置いた情報記憶用磁気記憶媒体水を、抗体又は抗体の情報を記憶させた磁気記憶媒体などの物体を置いた直線磁場のS極寄りに置いた後、セラミック材料に混合して乾燥・焼成してなる情報記憶済みセラミックス体Close to the north pole of the linear magnetic field generated between the opposing faces of the north and south poles of the magnet having the magnetic force necessary to store the substance information in the magnetic storage medium, An object such as a magnetic storage medium in which a magnetic storage medium storing these pieces of information is disposed, and an information storage magnetic storage medium water placed in a curved magnetic field outside the linear magnetic field is stored in an antibody or antibody information. An information-stored ceramic body that is placed near the S pole of a linear magnetic field and then mixed with a ceramic material and dried and fired
JP19505198A 1998-06-25 1998-06-25 Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body Expired - Fee Related JP4183800B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19505198A JP4183800B2 (en) 1998-06-25 1998-06-25 Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19505198A JP4183800B2 (en) 1998-06-25 1998-06-25 Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body

Publications (2)

Publication Number Publication Date
JP2000005326A JP2000005326A (en) 2000-01-11
JP4183800B2 true JP4183800B2 (en) 2008-11-19

Family

ID=16334742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19505198A Expired - Fee Related JP4183800B2 (en) 1998-06-25 1998-06-25 Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body

Country Status (1)

Country Link
JP (1) JP4183800B2 (en)

Also Published As

Publication number Publication date
JP2000005326A (en) 2000-01-11

Similar Documents

Publication Publication Date Title
Farzanfar The use of probiotics in shrimp aquaculture
Misra et al. Changes in lysosomal enzyme activity and protection against Vibrioinfection in Macrobrachium rosenbergii (De Man) post larvae after bath immunostimulation with β-glucan
US11266168B2 (en) Probiotic bacteria for fish
Wongtavatchai et al. Effect of AquaVacTM VibromaxTM on size and health of post larva stage of Pacific White shrimp Litopenaeus vannamei and Black Tiger shrimp Penaeus monodon
DK202070450A1 (en) Probiotic bacteria for fish
Plumb Overview of warmwater fish diseases
Loh et al. Fish vetting essentials
Vercauteren et al. Scrutinizing the triad of Vibrio tapetis, the skin barrier and pigmentation as determining factors in the development of skin ulcerations in wild common dab (Limanda limanda)
JP5553337B2 (en) Marine fish white spot disease preventive and therapeutic agent
JP4183800B2 (en) Disease prevention / treatment method for organisms other than human body, information storage medium used in this method, and information-stored ceramic body
Hameed et al. Studies on the chemical control of a Vibrio campbellii-like bacterium affecting hatchery-reared Penaeus indicus larvae
TW513289B (en) Prophylactic and therapeutic agent for infectious disease of fishes and shellfishes
CN106727471A (en) Inositol as Florfenicol synergist application
JP3151068B2 (en) How to insert pearl nuclei into pearl oysters
JP2583473B2 (en) Remedies for vibrio infectious disease and treatment and prevention using the same
Maeda Interactions of microorganisms and their use as biocontrol agents in aquaculture
JPH0748274A (en) Production of preventing and therapeutic feed for pathogenic microbism in farming fishery
Felix Pro-PO based immunomodulatory effect of glucan and LPS on tiger shrimp, Peneaus monodon (Fabricus)
JP6012013B2 (en) Method for incorporating useful components into the body of aquatic organisms, and aquatic organisms obtained using the same
JP2001342141A (en) Medicine and feed for aquatic animal and land animal
JP4275431B2 (en) Drugs for the treatment of bacterial cold water disease using bacteriophages
Jee et al. Trials for the control of scuticociliatosis in the cultured olive flounder (paralkhthys olivaceus) by bath treatment
Dvornak et al. Husbandry of Bowmouth Guitarfish, Rhina ancylostoma
Sahu et al. Research on Immunostimulants in Aquaculture with Special Reference to Shrimp Culture.
JPH02215327A (en) Method for preventing disease in cultured fish

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080417

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080616

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080616

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080718

TRDD Decision of grant or rejection written
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080718

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080829

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080903

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110912

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110912

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120912

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120912

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130912

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees